Ashley Couvillion
Family · Belle Chasse, LANPI 1124652235
Payments from drug & device makers
Across 79 payments — averaging $27.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$445
- Lilly USA, LLC$224
- Revance Therapeutics, Inc.$144
- GSK$143
- Dermavant Sciences, Inc.$125
- Teva Pharmaceuticals USA, Inc.$123
- plus $949 from 19 others
What the payments were for
- Food & beverage$2,154100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $445 |
| Lilly USA, LLC | 9 | $224 |
| Revance Therapeutics, Inc. | 2 | $144 |
| GSK | 6 | $143 |
| Dermavant Sciences, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Johnson & Johnson | 1 | $115 |
| Galderma Laboratories, L.p. | 2 | $110 |
| Itamar Medical Inc | 1 | $98 |
| Neurelis, Inc. | 1 | $82 |
| Supernus Pharmaceuticals, Inc. | 2 | $68 |
| Boehringer Ingelheim | 4 | $66 |
| Amgen | 4 | $62 |
| Exact Sciences | 3 | $60 |
| Abbott | 3 | $56 |
| Merck | 3 | $56 |
| Atricure, Inc. | 1 | $32 |
| Viiv Healthcare Company | 1 | $28 |
| Bayer | 1 | $20 |
| Gilead | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Corium, LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Organon | 1 | $14 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VTAMA$125
- Austedo XR$123
- DAXI$116
- SPRAVATO$115
How this compares
$2,154 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $26,428 |
| JardianceEmpagliflozin | 13 | $20,134 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $13,145 |
| FarxigaDapagliflozin Propanediol | 11 | $7,961 |
| XareltoRivaroxaban | 11 | $6,904 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,942 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,513 |
| Gabapentin | 55 | $1,039 |
| Duloxetine Hcl | 29 | $707 |
| Atorvastatin Calcium | 97 | $695 |
| Levocetirizine Dihydrochloride | 24 | $557 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $521 |
| Hydroxyzine Hcl | 31 | $505 |
| Fluticasone Propionate | 36 | $375 |
| Ezetimibe | 15 | $366 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $16 | $26,42820 claims |
| Boehringer IngelheimJardiance | $66 | $20,13413 claims |
| GSKTrelegy Ellipta | $143 | $13,14516 claims |
| AstraZenecaFarxiga, Symbicort | $13 | $10,90423 claims |
| Johnson & JohnsonXarelto | $115 | $6,90411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,610 family providers in Louisiana.
Other family in Belle Chasse
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.